DocSym
β
Searchsearch
Search
(Y49.3) Phenothiazine antipsychotics and neuroleptics
More details coming soon
41 630 in individuals diagnosis phenothiazine antipsychotics and neuroleptics confirmed
2 424 deaths with diagnosis phenothiazine antipsychotics and neuroleptics
6% mortality rate associated with the disease phenothiazine antipsychotics and neuroleptics
Diagnosis phenothiazine antipsychotics and neuroleptics is diagnosed Women are 41.95% more likely than Men
12 083
Men receive the diagnosis phenothiazine antipsychotics and neuroleptics
710 (5.9 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
29 547
Women receive the diagnosis phenothiazine antipsychotics and neuroleptics
1 714 (5.8 %)Died from this diagnosis.
Risk Group for the Disease phenothiazine antipsychotics and neuroleptics - Men aged 15-19 and Women aged 20-24
In Men diagnosis is most often set at age 5-9, 15-29, 35-54, 65-79
Less common in men the disease occurs at Age 0-5, 10-14, 30-34, 55-64, 80-95+Less common in women the disease occurs at Age 0-5, 80-84, 90-95+
In Women diagnosis is most often set at age 5-79, 85-89
Disease Features phenothiazine antipsychotics and neuroleptics
Absence or low individual and public risk
Phenothiazine antipsychotics and neuroleptics - what does this mean
Phenothiazine antipsychotics and neuroleptics are medications that work by blocking dopamine receptors in the brain. this results in a decrease in dopamine activity, which can help reduce psychotic symptoms such as hallucinations, delusions, and disorganized thinking. these medications can also help with other mental health issues, such as anxiety, depression, and aggression.
What happens during the disease - phenothiazine antipsychotics and neuroleptics
Phenothiazine antipsychotics and neuroleptics act on the central nervous system to reduce the symptoms of certain mental illnesses. they work by blocking dopamine receptors in the brain, which helps to reduce the activity of neurons that have been over-stimulated and causing the symptoms of the mental illness. this blocking of dopamine receptors also helps to reduce the amount of dopamine in the brain, which can help to reduce the intensity and frequency of psychotic episodes.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Physical examination
- Blood tests
- Imaging studies (CT scan, MRI, PET scan)
- Neuropsychological testing
- Psychological evaluation
- Urine drug screen
- Genetic testing
- Neurological examination
- Electroencephalogram (EEG)
- Lumbar puncture (spinal tap)
Treatment and Medical Assistance
Main Goal: To reduce the symptoms associated with Phenothiazine antipsychotics and neuroleptics
- Close monitoring of patient's physical and mental health
- Regularly scheduled visits with a physician
- Medication management and dose adjustment
- Psychotherapy, such as cognitive behavioral therapy (CBT)
- Family therapy
- Social skills training
- Relaxation techniques
- Support groups
- Exercise and healthy diet
10 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Phenothiazine antipsychotics and neuroleptics - Prevention
The best way to prevent the use of phenothiazine antipsychotics and neuroleptics is through early detection and management of mental health issues. this includes regular mental health check-ups and screenings, as well as timely intervention for any signs of mental health issues. additionally, education about mental health and its associated risks can help reduce the need for these medications.